As the prevalence of the new COVID-19 variant, JN.1, continues to surge nationwide, grasping the intricacies of COVID-19 testing billing has become paramount. Recent data from the U.S. Centers for Disease Control and Prevention reveals that JN.1 now constitutes 44% of all COVID-19 infections in the country, underscoring the need for streamlined testing procedures and...Read More